News archive

2012, April 17: to-BBB receives Michael J. Fox Foundation funding for Parkinson's disease research 2011, December 19: to-BBB receives International Innovation grant to support partnership with top-5 pharma company 2011, October 15: Volkskrant: to-BBB in cover feature of popular science section (Dutch) 2011, October 5: EuropaBio: to-BBB shortlisted for EuropaBio's Most Innovative European Biotech SME Award 2011 2011, September 29: NeuroVive and to-BBB awarded Eurostars grant for development of stroke therapy 2011, September 8: DeGids.fm: Pieter Gaillard explains clinical development 2B3-101 for brain cancer on radio (Dutch) 2011, August 29: to-BBB builds for success with Chief Medical Officer and new group of investors 2011, July 19: EmulTech and to-BBB announce development partnership 2011, June 27: to-BBB start klinische studie in patienten met hersenmetastasen (Dutch) 2011, June 27: to-BBB starts clinical trial in patients with brain metastases 2011, May 7: BioNieuws: Medicijnen verpakt in lichaamseigen jasje (Dutch) 2011, March 31: to-BBB obtains government loan of EUR 1.2 million for clinical trial in brain cancer 2011, February 3: to‐BBB
 realizes 
EUR 4 million investment round 2011, January 5: Synageva Biopharma Corp and to-BBB to collaborate on brain drug delivery for rare diseases 2010, December: Innovations in Pharmaceutical Technology: Enhanced Blood to Brain Drug Delivery 2010, November 4: SciBx: LAMbasting brain cancer 2010, October 28: FD: Piepjong to-BBB ziet 'exit' in vier jaar (Dutch) 2010, October 25: NeuroVive and to-BBB to jointly develop therapy for stroke 2010, August 23: FDA grants Orphan Drug Status for to-BBBs lead product 2010, August 1: Neurotech Insights: to-BBB leverages new platform to target brain tumors, form partnerships 2010, July 16: First two ODD-support grants awarded to DNage and to-BBB 2010, July 7: NRC Handelsblad: BSP Leiden is voorbeeld voor Organon (Dutch) 2010, June 14: to-BBB receives positive opinion for Orphan Drug Designation 2010, June 1: MedLabNews: Beating the Barrier 2010, June 1: Quest: Medicijn in vermomming (Dutch) 2010, June 1: VSNU: The power of knowledge 2010, May 20: to-BBB announces brain drug delivery pilot study with Janssen Pharmaceutica NV for CNS diseases 2010, March 3: to-BBB and GSK to collaborate on brain delivery of a biologic product 2010, January 7: to-BBB announces two additional pharma collaborations on brain drug delivery 2010, January 1: Drug Delivery: to-BBB-breaking down brain barriers 2009, December 22: to-BBB and Lundbeck to join forces on brain delivery of antibodies for CNS diseases 2009, November 13: Management Team: Hersentumor te lijf 2009, November 3: to-BBB announces collaboration Genzyme on brain delivery of biologics for neurodegenerative diseases 2009, October 26: BioCentury: Breaking through the BBB 2009, October 21: Corvitex and to-BBB join forces to raise funds in the USA 2009, September 17: to-BBB technology will be used by MedImmune to evaluate brain drug delivery mechanism 2009, August 20: Acceleration of the development of to-BBBs brain cancer treatment 2009, August 6: to-BBB climbs up the international CNS drug delivery ranking 2009, July 21: to-BBB selected to present at BioBusiness Asia 2009 2009, July 9: Professor Bart de Strooper and to-BBB to collaborate on brain delivery of anti-Alzheimer antibodies 2009, July 1: to-BBB to receive Outstanding Presentation Award at 8th Cerebral Vascular Biology International Conference 2009, June 23: FD: Biotechstarter zoekt kapitaal (Dutch) 2009, June 22: The Netherlands Cancer Institute (NKI) and to-BBB to collaborate on brain delivery of anti-cancer drugs 2009, June 10: to-BBB invited to present at BioEquity Europe 2009, May 12: TNO: Better treatment for nerve gas poisoning on the horizon 2009, May 12: U.S. Army funds TNO, and to-BBB to investigate protecting soldiers brains from nerve agents 2009, April 30: to-BBB to present at International Advanced Drug Delivery Symposium 2009, April 21: to-BBB invited to pitch at BioCapital Europe 2009, March 19: NRC Next: Medicijnen de hersenen in smokkelen (Dutch) 2009, March 7: C2W: Start-up als gespreid bedje (Dutch) 2009, February 28: FEM: Ik heb meer impact op het eindresultaat (Dutch) 2009, February 3: Blood-brain barrier company to-BBB moves into commercialization mode with new CEO Willem van Weperen 2009, February 1: GEN: Strategies to Overcome Blood-Brain Barrier 2008, December 1: to-BBB to present at GCTbio's CNS diseases partnering & deal-making summit 2008, November 19: to-BBB invited to present at BIO-Europe 2008 2008, November 12: Dutch biotech company to-BBB and Taiwanese ITRI sign exclusive license agreement 2008, May 28: to-BBB invited to pitch at BioEquity Europe 2008, May 25: to-BBB covered in three pharma industry market reports 2008, May 08: to-BBB invited speaker at The Neurotech Industry Investing & Partnering Conference 2008, April 11: to-BBB secures Challenger's Loan 2008, March 28: to-BBB elects Mats Petterson and Jaap Blaak to its supervisory board 2008, January 1: to-BBB moves into new premises 2007, November 13: to-BBB rewrites corporate vision and mission statements 2007, November 3: Antea nieuwsbrief A tot Z: to-BBB dichter bij beursgang (Dutch) 2007, October 1: to-BBB advances management team 2007, September 29: C2W: Serum als paard van Troje (Dutch) 2007, July 6: Aescap Venture invests EUR 4 million in to-BBB 2007, June 16: FEM Business, TECH25: de briljantste bedrijven van Nederland (Dutch) 2007, March 21: CNS drug targeting technology 2B-Trans to be part of Dutch Technology Foundation grant 2006, December 27: CNS drug targeting technology 2B-Trans part of International Stichting Alzheimer Onderzoek grant 2006, May 24: NVP Financial Insights: Zonder private equity geen groei in Nederland (Dutch) 2005, December 8: CNS drug targeting technology 2B-Trans to be part of Dutch Technology Foundation grant 2005, October 20: to-BBB secures grant from Sanfilippo Foundation 2005, June 11: FEM Business; TECH25: de briljantste bedrijven van Nederland (Dutch) 2005, May 31: FD: Medisch paard van Troje (Dutch) 2005, May 24: to-BBB signs agreement with Genmab on 2B-Trans technology 2005, March 21: to-BBB eerste in tender Innovatiesubsidie Samenwerkingsprojecten (Dutch) 2005, March 14: to-BBB announces research collaboration with Biogen Idec 2004, September 8: Leidsch dagblad: Eiwit met rugzakje brengt medicijn naar het brein (Dutch) 2004, June 5: FEM Business; TECH25: de briljantste bedrijven van Nederland (Dutch)